Quantifying and reducing the burden of new and emerging psychoactive substances in Australia

新出现的令人关注的药物(如新的精神活性物质和结晶甲基苯丙胺)构成的公共卫生威胁需要及时和有效的公共卫生干预。这项研究计划将加强对全球核动力源健康负担的估计，加强对不知情药物消费的监测，并开发和评估新的减少危害的反应。调查结果将为全球和澳大利亚国内的政策和卫生服务提供提供信息。

The public health threat posed by emerging drugs of concern (e.g., new psychoactive substances (NPS) and crystalline methamphetamine) requires timely and effective public health interventions. This research program will strengthen estimates of the global NPS health burden, enhance the surveillance of unwitting drug consumption, and develop and evaluate novel harm reduction responses. Findings will inform policy and health service delivery, both globally and within Australia.